Avid Bioservices Inc (CDMO)

[JamesGMS]

MH, thanks for your thoughts. A question - did you happen to see the recent MF article wherein a few statements attributed to Gilead President and COO John Milligan were reported?

Here's the link to the article:

http://www.fool.com/investing/general/2015/09/23/247-billion-says-gilead-is-up-to-something.aspx

I was particularly intrigued by the following:

Milligan noted earlier this year at the Goldman Sachs Healthcare Conference that Gilead hopes to find something to weld a particular portfolio together.

So both for cancer and for inflammatory disease, we don't have a cornerstone molecule, the kind of thing that we have with Viread for our HIV program, which will be replaced by TAF as the cornerstone or Sovaldi for the use in HCV. We don't yet have that, so that is the thing that we're looking for. And those things either kind of emerge from the pipeline, as I mentioned, or they can emerge from M&A if that -- we saw that kind of cornerstone product.

In your experience, would you characterize Bavi as possibly being the type of "cornerstone molecule" Gilead might be looking for?

TIA for your thoughts.

James